MedPath

HUMALOG

HUMALOG

Approved
DIN Number

02229704

Drug Class

Human

Market Date

Nov 15, 1996

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02229704
AIG Number0131614001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AB04 INSULIN LISPRO
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Subcutaneous ,  Intravenous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

INSULIN LISPROActive
Strength: 100 UNIT / ML
Monograph: INSULIN LISPRO

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.